Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Arch Ophthalmol. 2012 Feb 13;130(4):497–505. doi: 10.1001/archophthalmol.2011.2727

Table 2.

Cost Effectiveness of Treating Newly Diagnosed Mild Open-Angle Glaucoma Using Prostaglandin Analogs, Laser Trabeculoplasty, or No Treatment

Intervention Cost ($) Incremental Costs Effectiveness (QALYs) Incremental Effectiveness Incremental cost effectiveness
No Treatment 2700 16.06
LTP 13788 11088 16.71 0.65 $16824/ QALY
PGAs 18101 15401 17.14 1.09 $14179/ QALY

LTP = laser trabeculoplasty; PGAs = prostaglandin analogues; QALY = quality-adjusted life year